| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.003 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |